---
title: "Tinavi Medical Technologies Co.,Ltd. (688277.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688277.SH.md"
symbol: "688277.SH"
name: "Tinavi Medical Technologies Co.,Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T09:38:36.668Z"
locales:
  - [en](https://longbridge.com/en/quote/688277.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688277.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688277.SH.md)
---

# Tinavi Medical Technologies Co.,Ltd. (688277.SH)

## Company Overview

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; and TiRobot instrument comprising hand surgery locating, as well as cervical, hip, and foot and ankle surgery toolkits. It also provides robotic-guided orthopedic surgical systems; and supporting equipment and consumables.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.tinavi.com](https://www.tinavi.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.50)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 41 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 30.93% |  |
| Net Profit YoY | -73.81% |  |
| P/B Ratio | 7.75 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8985317164.75 |  |
| Revenue | 273442398.92 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -17.53% | E |
| Profit Margin | -79.13% | E |
| Gross Margin | 63.87% | A |
| Revenue YoY | 30.93% | A |
| Net Profit YoY | -73.81% | E |
| Total Assets YoY | -5.20% | D |
| Net Assets YoY | -9.71% | D |
| Cash Flow Margin | 56.57% | C |
| OCF YoY | 30.93% | A |
| Turnover | 0.16 | D |
| Gearing Ratio | 27.47% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Tinavi Medical Technologies Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "30.93%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-73.81%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "7.75",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "8985317164.75",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "273442398.92",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-17.53%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-79.13%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "63.87%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "30.93%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-73.81%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.20%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-9.71%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "56.57%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "30.93%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.16",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "27.47%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -41.53 | 56/64 | - | - | - |
| PB | 7.75 | 61/64 | 8.31 | 6.45 | 5.33 |
| PS (TTM) | 32.86 | 65/64 | 39.60 | 32.90 | 28.32 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-06T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 14.44 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688277.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688277.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688277.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**